Showing 719 news articles about Side effects

Filters Content type: News Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Quality of life

HIV clinicians in Spain underestimate their patients’ HIV-related symptoms

News
5 April 2024
Changing treatment

Increasing and changing pattern of treatment switches among people with HIV

News
23 October 2023
Cardiovascular disease

Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn

News
23 October 2023
Side effects

Integrase inhibitors more likely to be linked to depression and suicidality than other HIV drugs

News
24 August 2023
Diabetes

No link between weight gain on integrase inhibitors and diabetes

News
12 July 2023
Drug interactions & pharmacokinetics

Can testing for drug-gene interactions improve treatment success in people with HIV?

News
15 June 2023
PrEP science

Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact

News
30 December 2022
Side effects

CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention

News
27 October 2022
Bone & joint problems

Vitamin D and calcium supplements suggested to avert bone disease in people taking tenofovir-based ART and PrEP

News
24 August 2022
Weight gain & lipodystrophy

Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains

News
29 July 2022
PEP

Study shows Biktarvy for PEP has fewer side effects and better completion rates

News
16 March 2022
Bone & joint problems

Better adherence to PrEP is associated with more bone loss

News
9 March 2022
Side effects

Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012

News
28 October 2021
Cardiovascular disease

Large US study confirms that people switching from TDF to TAF experience rising blood fat levels

News
15 October 2021
Weight gain & lipodystrophy

Older version of tenofovir used as PrEP linked to weight loss

News
5 October 2021
PrEP science

Most switches to Descovy PrEP are probably unnecessary and some may be harmful

News
1 October 2021
Kidney problems

People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP

News
21 September 2021
Neurological & cognitive problems

New predictors for peripheral neuropathy found in study of people living with HIV

News
6 July 2021
Treatment outcomes & life expectancy

Spanish studies highlight scale of late presentation and its consequences for treatment

News
24 June 2021
Sexual health

Delayed HIV treatment initiation and protease inhibitors associated with erectile dysfunction in men living with HIV

News
31 May 2021
Bone & joint problems

Alendronate can prevent bone loss in people starting HIV treatment

News
9 March 2021
Side effects

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

News
5 January 2021
Weight gain & lipodystrophy

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

News
2 October 2020
Diabetes

No increased risk of diabetes with integrase inhibitors in people starting HIV treatment

News
11 September 2020